Nothing Special   »   [go: up one dir, main page]

HUP0000716A2 - Fekélyes kolitisz és/vagy Crohn-féle betegség megelőzésére és kezelésére alkalmas gyógyszerkészítmény - Google Patents

Fekélyes kolitisz és/vagy Crohn-féle betegség megelőzésére és kezelésére alkalmas gyógyszerkészítmény

Info

Publication number
HUP0000716A2
HUP0000716A2 HU0000716A HUP0000716A HUP0000716A2 HU P0000716 A2 HUP0000716 A2 HU P0000716A2 HU 0000716 A HU0000716 A HU 0000716A HU P0000716 A HUP0000716 A HU P0000716A HU P0000716 A2 HUP0000716 A2 HU P0000716A2
Authority
HU
Hungary
Prior art keywords
crohn
disease
preventives
remedies
ulcerous colitis
Prior art date
Application number
HU0000716A
Other languages
English (en)
Inventor
Masakazu Fukushima
Masaaki Ishizuka
Kenji Maeda
Tadayoshi Shiraishi
Tomio Takeuchi
Original Assignee
Taiho Pharmaceutical Co., Ltd.
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co., Ltd., Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai filed Critical Taiho Pharmaceutical Co., Ltd.
Publication of HUP0000716A2 publication Critical patent/HUP0000716A2/hu
Publication of HUP0000716A3 publication Critical patent/HUP0000716A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Soy Sauces And Products Related Thereto (AREA)

Abstract

A találmány tárgya gyógyszer fekélyes kőlitisz és/vagy Crőhn-betegségmegelőzésére vagy kezelésére, amely hatóanyagként kőnagenint vagyannak valamely gyógyászatilag elfőgadható sóját főglalja magába. Ajelen találmány szerinti gyógyszer fekélyes kőlitisz és/vagy Crőhn-betegség megelőzésére és/vagy kezelésére nagy terápiás hatással ésbiztőnsággal alkalmazható. ŕ
HU0000716A 1997-04-09 1998-04-08 Preventives and remedies for ulcerous colitis and/or crohn's disease HUP0000716A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9068897 1997-04-09
PCT/JP1998/001614 WO1998044916A1 (fr) 1997-04-09 1998-04-08 Medicaments de prevention ou de traitement de la recto-colite hemorragique et/ou de la maladie de crohn

Publications (2)

Publication Number Publication Date
HUP0000716A2 true HUP0000716A2 (hu) 2000-09-28
HUP0000716A3 HUP0000716A3 (en) 2000-10-30

Family

ID=14005483

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000716A HUP0000716A3 (en) 1997-04-09 1998-04-08 Preventives and remedies for ulcerous colitis and/or crohn's disease

Country Status (11)

Country Link
US (1) US6160017A (hu)
EP (1) EP0987022B1 (hu)
JP (1) JP4019158B2 (hu)
KR (1) KR100356899B1 (hu)
AT (1) ATE316373T1 (hu)
AU (1) AU727289B2 (hu)
CA (1) CA2288966C (hu)
DE (1) DE69833317D1 (hu)
HU (1) HUP0000716A3 (hu)
NO (1) NO994930L (hu)
WO (1) WO1998044916A1 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007011066A1 (ja) * 2005-07-22 2007-01-25 Kaneka Corporation 繊維芽細胞賦活剤、コラーゲン産生促進剤、コラーゲン収縮促進剤、ヒアルロン酸産生促進剤、ａｔｐ産生促進剤、メラニン生成抑制剤、皮膚外用剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4078397B2 (ja) * 1994-10-14 2008-04-23 財団法人微生物化学研究会 下痢の予防及び治療剤

Also Published As

Publication number Publication date
HUP0000716A3 (en) 2000-10-30
US6160017A (en) 2000-12-12
AU6746898A (en) 1998-10-30
JP4019158B2 (ja) 2007-12-12
KR100356899B1 (ko) 2002-10-31
KR20010006136A (ko) 2001-01-26
AU727289B2 (en) 2000-12-07
CA2288966C (en) 2004-03-16
NO994930D0 (no) 1999-10-08
CA2288966A1 (en) 1998-10-15
WO1998044916A1 (fr) 1998-10-15
DE69833317D1 (de) 2006-04-13
EP0987022A1 (en) 2000-03-22
EP0987022B1 (en) 2006-01-25
NO994930L (no) 1999-12-08
EP0987022A4 (en) 2004-03-31
ATE316373T1 (de) 2006-02-15

Similar Documents

Publication Publication Date Title
KR920019342A (ko) 골질환 치료제
KR960703009A (ko) 중추유래의 수면성 무호흡증 및 호흡곤란증의 치료를 위한 모다피닐의 사용
GR3025502T3 (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals.
KR960700742A (ko) 아토피성질환 치료약(atopic disease remedy)
KR940006578A (ko) 2-(3,4-디메톡신나모일) 아미노벤조산
MX9400287A (es) Procedimiento para la preparacion de un medicamento util para el tratamiento de la enfermedad de parkinson
ATE282418T1 (de) Orale verabreichung wirksamer mengen von hyaluronsäure
MX9501849A (es) Nuevos compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
KR970032872A (ko) 아세틸살리실산을 함유하는 피부 손상 처치용 약물
HUP0000716A2 (hu) Fekélyes kolitisz és/vagy Crohn-féle betegség megelőzésére és kezelésére alkalmas gyógyszerkészítmény
ES2104223T3 (es) 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori.
GR3032224T3 (en) Therapeutic agent for threatened abortion.
GR3034062T3 (en) Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
WO2000043014A8 (en) Beta-d-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine for use in the treatment of hiv infections
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
FR2818147B1 (fr) Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine
ATE93723T1 (de) 5-methoxypsoralen gegen depressionen.
BR0013741A (pt) Composto, processo para a preparação de um composto, medicamento, agente terapêutico ou profilático para doenças infecciosas fúngicas, cepa, uso de um composto, método para o tratamento ou a prevenção de uma infecção fúngica, e, composição farmacêutica
FR2801793B1 (fr) Association d'une ergoline et de riluzole et son utilisation comme medicament
RU94016144A (ru) Средство для лечения больных болезнью рейтера
UA30143A (uk) Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань
EP1731155A3 (en) Beta-d-2', 3' -didehydro-2', 3' -dideoxy-5-fluorocytidine for use in the treatment of hiv infections
KR890000089A (ko) 신장 질환 치료제
NO307204B1 (no) Anvendelse av riluzol ved fremstilling av medikamenter ved behandling av stråleskader
HUP0200148A2 (hu) N-(3',4'-dimetoxi-cinnamoil)antranilsav alkalmazása szívkoszorúér-műtéttel kapcsolatos cardiovascularis események megelőzésére vagy mérséklésére

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees